LP28442-9	STY	Amino Acid, Peptide, or Protein		LNC
LP28442-9	STY	Enzyme		LNC
LP28442-9	STY	Receptor		LNC
LP28442-9	PT	HER2		LNC
LP28442-9	CHD	 Pathology	LNC
LP28442-9	PAR	 HER2 [Presence] in Tissue by FISH	LNC
LP28442-9	PAR	 HER2/CEP17 [Ratio] in Tissue by FISH	LNC
LP28442-9	PAR	 HER2 and#x7C; bld-ser-plas	LNC
LP28442-9	PAR	 HER2 and#x7C; Tissue and Smears	LNC
LP28442-9	PAR	 HER2 signals	LNC
LP28442-9	PAR	 CEP17 signals	LNC
LP28442-9	PAR	 HER2 [Presence] in Breast cancer specimen by FISH	LNC
LP28442-9	PAR	 Cells.HER2 uniform intense membrane staining and#x7C; Breast cancer specimen	LNC
LP28442-9	PAR	 HER2 and#x7C; Breast cancer specimen	LNC
LP28442-9	RO	component of HER2 Ag [Presence] in Tissue by Immune stain	LNC
LP28442-9	RO	component of HER2 [Mass/volume] in Serum	LNC
LP28442-9	RO	component of HER2 [Mass/volume] in Serum by Immunoassay	LNC
LP28442-9	RO	component of Deprecated HER2 in Tissue by FISH Nominal	LNC
LP28442-9	RO	component of HER2 [Interpretation] in Tissue	LNC
LP28442-9	RO	component of HER2 [Presence] in Serum by Immunoassay	LNC
LP28442-9	RO	component of HER2 [Presence] in Tissue by Immunoassay	LNC
LP28442-9	RO	component of HER2 [Units/volume] in Tissue by Immunoassay	LNC
LP28442-9	RO	component of HER2 panel - Tissue by FISH	LNC
LP28442-9	RO	component of HER2 signals/nucleus [Entitic number] in Tissue by FISH	LNC
LP28442-9	RO	component of HER2 [Presence] in Breast cancer specimen by Immune stain	LNC
LP28442-9	RO	component of Cells.HER2 uniform intense membrane staining/100 cells in Breast cancer specimen by Immune stain	LNC
LP39016-8	STY	Amino Acid, Peptide, or Protein		LNC
LP39016-8	STY	Indicator, Reagent, or Diagnostic Aid		LNC
LP39016-8	STY	Immunologic Factor		LNC
LP39016-8	PT	Ki-67 nuclear Ag		LNC
LP39016-8	RO	component of Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain	LNC
LP39016-8	RO	component of Ki-67 nuclear Ag [Presence] in Tissue by Immune stain	LNC
LP39016-8	RO	component of Cells.Ki-67 nuclear Ag/100 cells in Breast cancer specimen by Immune stain	LNC
LP18567-5	STY	Amino Acid, Peptide, or Protein		LNC
LP18567-5	STY	Receptor		LNC
LP18567-5	PT	Estrogen receptor		LNC
LP18567-5	CHD	 Pathology	LNC
LP18567-5	PAR	 Estrogen receptor and#x7C; Tissue and Smears	LNC
LP18567-5	PAR	 Cells.estrogen receptor	LNC
LP18567-5	PAR	 Estrogen receptor and#x7C; Breast cancer specimen	LNC
LP18567-5	PAR	 Estrogen receptor fluorescence intensity and#x7C; Breast cancer specimen	LNC
LP18567-5	RO	component of Estrogen receptor [Moles/mass] in Tissue	LNC
LP18567-5	RO	component of Cells.estrogen receptor/100 cells in Tissue by Immune stain	LNC
LP18567-5	RO	component of Estrogen receptor [Interpretation] in Tissue	LNC
LP18567-5	RO	component of Estrogen receptor Ag [Presence] in Tissue by Immune stain	LNC
LP18567-5	RO	component of Cells.estrogen receptor/100 cells in Breast cancer specimen by Immune stain	LNC
LP18567-5	RO	component of Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain	LNC
LP18567-5	RO	component of Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain	LNC
LP15463-0	STY	Immunologic Factor		LNC
LP15463-0	STY	Organic Chemical		LNC
LP15463-0	PT	Cancer Ag 242		LNC
LP15463-0	RO	component of Cancer Ag 242 [Presence] in Serum or Plasma	LNC
LP232099-4	STY	Laboratory Procedure		LNC
LP232099-4	PT	Programmed cell death ligand 1 by clone 28-8		LNC
LP232099-4	RO	component of PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative	LNC
LP232099-4	RO	component of PD-L1 by clone 28-8 in Tissue by Immune stain Report	LNC
LP232099-4	RO	component of PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain	LNC
LP14040-7	STY	Immunologic Factor		LNC
LP14040-7	STY	Organic Chemical		LNC
LP14040-7	PT	Cancer Ag 19-9		LNC
LP14040-7	CHD	 Tumor markers	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; bld-ser-plas	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; Cerebral spinal fluid	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; body fluid	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; Pericardial fluid	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; Peritoneal fluid	LNC
LP14040-7	PAR	 Cancer Ag 19-9 and#x7C; pleural fluid	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Presence] in Serum or Plasma	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Pleural fluid	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Serum or Plasma	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Body fluid	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Pericardial fluid	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Peritoneal fluid	LNC
LP14040-7	RO	component of Deprecated Cancer Ag 19-9 [Presence] in Serum or Plasma	LNC
LP14040-7	RO	component of Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP232484-8	STY	Laboratory Procedure		LNC
LP232484-8	PT	Programmed cell death ligand 1 by clone SP142		LNC
LP232484-8	RO	component of PD-L1 by clone SP142 in Tissue by Immune stain Report	LNC
LP232484-8	RO	component of PD-L1 by clone SP142 [Presence] in Tissue by Immune stain	LNC
LP36806-5	STY	Pharmacologic Substance		LNC
LP36806-5	STY	Organic Chemical		LNC
LP36806-5	PT	5-Hydroxyindoleacetate & Creatinine		LNC
LP36806-5	SY	5-Hydroxyindoleacetate and Creatinine		LNC
LP36806-5	RO	component of 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine	LNC
LP36806-5	RO	component of 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine	LNC
LP36806-5	RO	component of 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine	LNC
LP36806-5	RO	component of 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine	LNC
LP36806-5	RO	component of 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine	LNC
LP14543-0	STY	Immunologic Factor		LNC
LP14543-0	STY	Organic Chemical		LNC
LP14543-0	PT	Cancer Ag 125		LNC
LP14543-0	CHD	 Tumor markers	LNC
LP14543-0	PAR	 Cancer Ag 125 [Presence] in Tissue by Immune stain	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; bld-ser-plas	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; Cerebral spinal fluid	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; body fluid	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; pleural fluid	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; peritoneal fluid	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; Dialysis fluid peritoneal	LNC
LP14543-0	PAR	 Cancer Ag 125 and#x7C; Pericardial fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Presence] in Serum or Plasma	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Serum or Plasma	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Body fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Body fluid by Dilution	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Pleural fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Peritoneal fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Cerebral spinal fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Pericardial fluid	LNC
LP14543-0	RO	component of Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP38116-7	STY	Amino Acid, Peptide, or Protein		LNC
LP38116-7	STY	Immunologic Factor		LNC
LP38116-7	PT	Estrogen+Progesterone receptor Ag		LNC
LP38116-7	RO	component of Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain	LNC
LP39481-4	STY	Amino Acid, Peptide, or Protein		LNC
LP39481-4	STY	Immunologic Factor		LNC
LP39481-4	PT	Progesterone receptor Ag		LNC
LP39481-4	RO	component of Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain	LNC
LP39481-4	RO	component of Progesterone receptor Ag [Presence] in Tissue by Immune stain	LNC
LP39481-4	RO	component of Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain	LNC
LP15097-6	STY	Organic Chemical		LNC
LP15097-6	PT	5-Hydroxyindoleacetate		LNC
LP15097-6	CHD	 Serotonin	LNC
LP15097-6	PAR	 5-hydroxyindoleacetate and#x7C; bld-ser-plas	LNC
LP15097-6	PAR	 5-hydroxyindoleacetate and#x7C; cerebral spinal fluid	LNC
LP15097-6	PAR	 5-hydroxyindoleacetate and#x7C; urine	LNC
LP15097-6	PAR	 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method	LNC
LP15097-6	PAR	 5-Hydroxyindoleacetate and#x7C; Platelet rich plasma	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Mass/volume] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Presence] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/volume] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate panel - 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Presence] in Urine	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma	LNC
LP15097-6	RO	component of 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma	LNC
LP18193-0	STY	Amino Acid, Peptide, or Protein		LNC
LP18193-0	STY	Immunologic Factor		LNC
LP18193-0	STY	Enzyme		LNC
LP18193-0	PT	Prostate specific Ag		LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Presence] in Tissue by Immune stain	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag/Prostate volume calculated from height, width and length	LNC
LP18193-0	RO	component of Prostate specific Ag/Prostate volume calculated from planimetry	LNC
LP18193-0	RO	component of Prostate specific Ag/Prostate volume calculated	LNC
LP18193-0	RO	component of Prostate specific Ag [Units/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Moles/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Units/volume] in Semen	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Semen	LNC
LP18193-0	RO	component of Prostate specific Ag [Moles/volume] in Semen	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Units/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Moles/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Units/volume] in Semen	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Semen	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Moles/volume] in Semen	LNC
LP18193-0	RO	component of Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Urine	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Body fluid	LNC
LP18193-0	RO	component of Prostate specific Ag/Creatinine [Mass Ratio] in Urine	LNC
LP18193-0	RO	component of Prostate specific Ag panel - Serum or Plasma	LNC
LP18193-0	RO	component of Deprecated Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Pleural fluid	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Peritoneal fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Cerebral spinal fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Pleural fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total in Cerebral spinal fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total in Peritoneal fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total in Pleural fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total in Body fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Body fluid	LNC
LP18193-0	RO	component of Prostate Specific Ag Free/Prostate specific Ag.total [Pure mass fraction] in Serum or Plasma	LNC
LP18193-0	RO	component of Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay	LNC
LP18193-0	RO	component of Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay	LNC
LP174002-8	STY	Quantitative Concept		LNC
LP174002-8	PT	Alpha-1-Fetoprotein multiple of the median cutoff		LNC
LP174002-8	RO	component of Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma	LNC
LP14652-9	STY	Hormone		LNC
LP14652-9	STY	Amino Acid, Peptide, or Protein		LNC
LP14652-9	STY	Indicator, Reagent, or Diagnostic Aid		LNC
LP14652-9	PT	Chromogranin A		LNC
LP14652-9	CHD	 Tumor markers	LNC
LP14652-9	PAR	 Chromogranin A Ag [Presence] in Tissue by Immune stain	LNC
LP14652-9	PAR	 Chromogranin A and#x7C; bld-ser-plas	LNC
LP14652-9	PAR	 Chromogranin A and#x7C; Body Fluid	LNC
LP14652-9	PAR	 Chromogranin A and#x7C; Cerebral spinal fluid	LNC
LP14652-9	PAR	 Chromogranin A and#x7C; Peritoneal fluid	LNC
LP14652-9	PAR	 Chromogranin A and#x7C; Pleural fluid	LNC
LP14652-9	RO	component of Chromogranin A [Mass/volume] in Serum or Plasma	LNC
LP14652-9	RO	component of Chromogranin A [Moles/volume] in Serum or Plasma	LNC
LP14652-9	RO	component of Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP14652-9	RO	component of Chromogranin A [Mass/volume] in Body fluid	LNC
LP14652-9	RO	component of Chromogranin A [Units/volume] in Pleural fluid	LNC
LP14652-9	RO	component of Chromogranin A [Units/volume] in Peritoneal fluid	LNC
LP14652-9	RO	component of Chromogranin A [Units/volume] in Cerebral spinal fluid	LNC
LP14652-9	RO	component of Chromogranin A [Units/volume] in Body fluid	LNC
LP14902-8	STY	Amino Acid, Peptide, or Protein		LNC
LP14902-8	STY	Receptor		LNC
LP14902-8	PT	Progesterone receptor		LNC
LP14902-8	CHD	 Pathology	LNC
LP14902-8	PAR	 Progesterone receptor and#x7C; Tissue and Smears	LNC
LP14902-8	PAR	 Cells.progesterone receptor	LNC
LP14902-8	PAR	 Progesterone receptor fluorescence intensity and#x7C; Breast cancer specimen	LNC
LP14902-8	PAR	 Progesterone receptor and#x7C; Breast cancer specimen	LNC
LP14902-8	RO	component of Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain	LNC
LP14902-8	RO	component of Progesterone receptor [Mass/mass] in Tissue	LNC
LP14902-8	RO	component of Cells.progesterone receptor/100 cells in Tissue by Immune stain	LNC
LP14902-8	RO	component of Progesterone receptor [Interpretation] in Tissue	LNC
LP14902-8	RO	component of Progesterone receptor [Moles/mass] in Tissue	LNC
LP14902-8	RO	component of Progesterone receptor Ag [Presence] in Tissue by Immune stain	LNC
LP14902-8	RO	component of Cells.progesterone receptor/100 cells in Breast cancer specimen by Immune stain	LNC
LP14902-8	RO	component of Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain	LNC
LP14902-8	RO	component of Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain	LNC
LP232100-0	STY	Laboratory Procedure		LNC
LP232100-0	PT	Programmed cell death ligand 1 by clone 22C3		LNC
LP232100-0	RO	component of PD-L1 by clone 22C3 in Tissue by Immune stain Report	LNC
LP232100-0	RO	component of PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative	LNC
LP232100-0	RO	component of PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain	LNC
LP247893-3	STY	Finding		LNC
LP247893-3	PT	Progesterone receptor fluorescence intensity		LNC
LP247893-3	RO	component of Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain	LNC
LP15466-3	STY	Amino Acid, Peptide, or Protein		LNC
LP15466-3	STY	Indicator, Reagent, or Diagnostic Aid		LNC
LP15466-3	STY	Immunologic Factor		LNC
LP15466-3	PT	Cancer Ag 549		LNC
LP15466-3	CHD	 Tumor markers	LNC
LP15466-3	PAR	 Cancer Ag 549 and#x7C; bld-ser-plas	LNC
LP15466-3	PAR	 Cancer Ag 549 and#x7C; pleural fluid	LNC
LP15466-3	RO	component of Cancer Ag 549 [Presence] in Serum or Plasma	LNC
LP15466-3	RO	component of Cancer Ag 549 [Units/volume] in Serum or Plasma	LNC
LP15466-3	RO	component of Cancer Ag 549 [Units/volume] in Pleural fluid	LNC
LP220351-3	STY	Immunologic Factor		LNC
LP220351-3	PT	Programmed cell death ligand 1		LNC
LP220351-3	CHD	 Specific antigens	LNC
LP220351-3	PAR	 PD-L1 by clone SP142 and#x7C; Tissue and Smears	LNC
LP220351-3	PAR	 PD-L1 by clone 28-8 and#x7C; Tissue and Smears	LNC
LP220351-3	PAR	 PD-L1 by clone 22C3 and#x7C; Tissue and Smears	LNC
LP220351-3	PAR	 Cells.programmed cell death ligand 1 and#x7C; Tissue and Smears	LNC
LP220351-3	RO	component of PD-L1 by clone 22C3 in Tissue by Immune stain Report	LNC
LP220351-3	RO	component of Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain	LNC
LP220351-3	RO	component of PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative	LNC
LP220351-3	RO	component of PD-L1 by clone SP142 in Tissue by Immune stain Report	LNC
LP220351-3	RO	component of PD-L1 by clone 28-8 in Tissue by Immune stain Report	LNC
LP220351-3	RO	component of PD-L1 by clone SP142 [Presence] in Tissue by Immune stain	LNC
LP220351-3	RO	component of PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain	LNC
LP220351-3	RO	component of PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative	LNC
LP220351-3	RO	component of PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain	LNC
LP15465-5	STY	Immunologic Factor		LNC
LP15465-5	STY	Organic Chemical		LNC
LP15465-5	PT	Cancer Ag 50		LNC
LP15465-5	RO	component of Cancer Ag 50 [Presence] in Serum or Plasma	LNC
LP15465-5	RO	component of Cancer Ag 50 [Units/volume] in Serum or Plasma	LNC
LP14907-7	STY	Amino Acid, Peptide, or Protein		LNC
LP14907-7	STY	Biologically Active Substance		LNC
LP14907-7	PT	Beta-2-Microglobulin		LNC
LP14907-7	CHD	 Beta 2 globulin	LNC
LP14907-7	PAR	 Beta-2-microglobulin and#x7C; bld-ser-plas	LNC
LP14907-7	PAR	 Beta-2-microglobulin and#x7C; body fluid	LNC
LP14907-7	PAR	 Beta-2-microglobulin and#x7C; cerebral spinal fluid	LNC
LP14907-7	PAR	 Beta-2-microglobulin and#x7C; Dialysis fluid	LNC
LP14907-7	PAR	 Beta-2-microglobulin and#x7C; urine	LNC
LP14907-7	PAR	 Beta-2-Microglobulin.tumor marker and#x7C; Bld-Ser-Plas	LNC
LP14907-7	PAR	 Beta-2-Microglobulin and#x7C; Peritoneal fluid	LNC
LP14907-7	PAR	 Beta-2-Microglobulin and#x7C; Pleural fluid	LNC
LP14907-7	PAR	 Beta-2-Microglobulin and#x7C; Dialysis fluid peritoneal	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Serum or Plasma	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/time] in 24 hour Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in Serum	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in Body fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Presence] in Serum	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Presence] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Presence] in Cerebral spinal fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Body fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Dialysis fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in 24 hour Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in 24 hour Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/time] in 24 hour Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Pleural fluid	LNC
LP14907-7	RO	component of Beta-2-Microglobulin/Creatinine [Ratio] in Urine	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Moles/volume] in Serum or Plasma	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis	LNC
LP14907-7	RO	component of Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid	LNC
LP28643-2	STY	Amino Acid, Peptide, or Protein		LNC
LP28643-2	STY	Immunologic Factor		LNC
LP28643-2	PT	Carcinoembryonic Ag		LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Semen	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Serum or Plasma	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Presence] in Tissue by Immune stain	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Units/volume] in Semen	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Body fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Units/volume] in Serum or Plasma	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Moles/volume] in Serum or Plasma	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Units/volume] in Pleural fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Pleural fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Moles/volume] in Pleural fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Pericardial fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid	LNC
LP28643-2	RO	component of Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay	LNC
LP18274-8	STY	Immunologic Factor		LNC
LP18274-8	PT	Cancer Ag DM-70K		LNC
LP18274-8	RO	component of Cancer Ag DM/70K [Units/volume] in Serum or Plasma	LNC
LP37027-7	STY	Amino Acid, Peptide, or Protein		LNC
LP37027-7	STY	Immunologic Factor		LNC
LP37027-7	PT	Alpha-1-fetoprotein Ag		LNC
LP37027-7	RO	component of Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain	LNC
LP268321-9	STY	Pharmacologic Substance		LNC
LP268321-9	STY	Amino Acid, Peptide, or Protein		LNC
LP268321-9	STY	Immunologic Factor		LNC
LP268321-9	PT	Alpha-1-Fetoprotein Ab		LNC
LP268321-9	RO	component of Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP37673-8	STY	Amino Acid, Peptide, or Protein		LNC
LP37673-8	STY	Immunologic Factor		LNC
LP37673-8	PT	Chromogranin A Ag		LNC
LP37673-8	RO	component of Chromogranin A Ag [Presence] in Tissue by Immune stain	LNC
LP15461-4	STY	Amino Acid, Peptide, or Protein		LNC
LP15461-4	STY	Immunologic Factor		LNC
LP15461-4	PT	Cancer Ag 15-3		LNC
LP15461-4	CHD	 Tumor markers	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; bld-ser-plas	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; Cerebral spinal fluid	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; body fluid	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; Pericardial fluid	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; Peritoneal fluid	LNC
LP15461-4	PAR	 Cancer Ag 15-3 and#x7C; pleural fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Presence] in Serum or Plasma	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Serum or Plasma	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Pleural fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Body fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Pericardial fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Peritoneal fluid	LNC
LP15461-4	RO	component of Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP14331-0	STY	Amino Acid, Peptide, or Protein		LNC
LP14331-0	STY	Biologically Active Substance		LNC
LP14331-0	PT	Alpha-1-Fetoprotein		LNC
LP14331-0	CHD	 Alpha 1 antitrypsin	LNC
LP14331-0	CHD	 Liver cancer antibodies and Alpha-1-Fetoprotein panel	LNC
LP14331-0	PAR	 Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; amniotic fluid	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; bld-ser-plas	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; body fluid	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; cerebral spinal fluid	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; Peritoneal fluid	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein and#x7C; pleural fluid	LNC
LP14331-0	PAR	 Alpha-1-fetoprotein L3 and#x7C; bld-ser-plas	LNC
LP14331-0	PAR	 Alpha-1-Fetoprotein and#x7C; Blood cord	LNC
LP14331-0	PAR	 Alpha-1-Fetoprotein.tumor marker and#x7C; Bld-Ser-Plas	LNC
LP14331-0	PAR	 Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Body fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Pleural fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] unadjusted in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Presence] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein interpretation in Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein interpretation in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Body fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Presence] in Amniotic fluid	LNC
LP14331-0	RO	component of Trisomy 21 risk based on maternal age+Alpha-1-Fetoprotein+Choriogonadotropin+Estriol.unconjugated [Likelihood] in Fetus	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein panel - Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein interpretation in Amniotic fluid Narrative	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Cord blood	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein panel - Amniotic fluid	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay	LNC
LP14331-0	RO	component of Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay	LNC
LP14331-0	RO	component of Liver cancer antibodies and AFP [Interpretation] in Serum or Plasma Qualitative	LNC
LP14331-0	RO	component of Liver cancer antibodies and AFP panel - Serum or Plasma by Immunoassay	LNC
LP247894-1	STY	Finding		LNC
LP247894-1	PT	Estrogen receptor fluorescence intensity		LNC
LP247894-1	RO	component of Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain	LNC
LP15464-8	STY	Amino Acid, Peptide, or Protein		LNC
LP15464-8	STY	Immunologic Factor		LNC
LP15464-8	PT	Cancer Ag 27-29		LNC
LP15464-8	CHD	 Tumor markers	LNC
LP15464-8	PAR	 Cancer Ag 27-29 and#x7C; bld-ser-plas	LNC
LP15464-8	PAR	 Cancer Ag 27-29 and#x7C; Cerebral spinal fluid	LNC
LP15464-8	PAR	 Cancer Ag 27-29 and#x7C; pleural fluid	LNC
LP15464-8	RO	component of Cancer Ag 27-29 [Presence] in Serum or Plasma	LNC
LP15464-8	RO	component of Cancer Ag 27-29 [Units/volume] in Serum or Plasma	LNC
LP15464-8	RO	component of Cancer Ag 27-29 [Units/volume] in Pleural fluid	LNC
LP15464-8	RO	component of Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid	LNC
LP15467-1	STY	Immunologic Factor		LNC
LP15467-1	STY	Organic Chemical		LNC
LP15467-1	PT	Cancer Ag 72-4		LNC
LP15467-1	CHD	 Tumor markers	LNC
LP15467-1	CHD	 Specific antigens	LNC
LP15467-1	PAR	 Cancer Ag 72-4 [Presence] in Tissue by Immune stain	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; bld-ser-plas	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; body fluid	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; pleural fluid	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; Cerebral spinal fluid	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; Pericardial fluid	LNC
LP15467-1	PAR	 Cancer Ag 72-4 and#x7C; Peritoneal fluid	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Presence] in Serum or Plasma	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Serum or Plasma	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Pleural fluid	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Body fluid	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Peritoneal fluid	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid	LNC
LP15467-1	RO	component of Cancer Ag 72-4 [Units/volume] in Pericardial fluid	LNC
